Abiopharma

News list

Duxbury Joseph 🟢 acquired 360.0K shares (1 derivative) of Vireo Growth Inc. (VREOF) Transaction Date: Aug 31, 2025 | Filing ID: 087050

Full text

News bot Sept. 3, 2025, 8:29 p.m.
🔍 Duxbury Joseph (Executive)

Company: Vireo Growth Inc. (VREOF)

Report Date: 2025-08-31
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 360,000
Detailed Transactions and Holdings:
- Acquired 360,000 shares of Restricted stock units (Derivative)
  Date: 2025-08-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 360,000.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Each restricted stock unit ("RSU") represents a contingent right to receive one subordinate voting share.
- F2: The RSUs vest on the following schedule: 120,000 RSUs on June 30, 2026; 30,000 RSUs on the last calendar day of each quarter thereafter until fully vested on June 30, 2028.
- REMARKS: Exhibit 24 - Power of Attorney